The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
2007

Impact of Smoking on Anal Cancer Treatment Outcomes

Sample size: 68 publication Evidence: moderate

Author Information

Author(s): Mai Sabine Kathrin, Welzel Grit, Haegele Verena, Wenz Frederik

Primary Institution: Department of Radiation Oncology of the University Medical Center Mannheim, Germany

Hypothesis

Does smoking during radiochemotherapy negatively affect the prognosis for anal cancer patients?

Conclusion

Smoking during radiochemotherapy for anal cancer may negatively influence prognosis, particularly affecting local control rates.

Supporting Evidence

  • Smokers had a local control rate of 74% compared to 94% for non-smokers.
  • Disease-specific survival for smokers was 82% versus 96% for non-smokers.
  • The study included 68 patients with complete data for evaluation.

Takeaway

Smoking can make it harder for patients with anal cancer to get better after treatment, so doctors should talk to patients about this before starting therapy.

Methodology

The study analyzed 68 patients treated with radiochemotherapy, comparing outcomes between smokers and non-smokers.

Potential Biases

The male:female ratio was significantly different between smokers and non-smokers, which may affect the results.

Limitations

The study is retrospective and lacks detailed quantitative data on smoking habits.

Participant Demographics

34 smokers and 34 non-smokers, with a mean age of 55 for smokers and 62 for non-smokers.

Statistical Information

P-Value

0.03

Confidence Interval

not provided

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1748-717X-2-30

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication